Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongzhou Lu

Showing results (11-20 of 444) with videos related to

Pageof 45
Sort By:
Drug Discoveries & Therapeutics|May 13, 2014
Suggestions to the media to help us cope with the A/H7N9 crisis in ChinaYang Sun, Hongzhou Lu
Global Health & Medicine|November 16, 2021
Prevalence, diagnosis, and treatment of hepatitis C in Mainland ChinaXue Mei, Hongzhou Lu
Bioscience Trends|March 22, 2021
New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antiviralsJun Chen, Hongzhou Lu
Bioscience Trends|April 8, 2016
Yellow fever in China is still an imported diseaseJun Chen, Hongzhou Lu
Drug Discoveries & Therapeutics|August 2, 2021
Less is more: A novel single-tablet regimen with two-drugs, dolutegravir/lamivudineJianjun Sun, Hongzhou Lu
Bioscience Trends|December 9, 2021
Clinical guidelines for the diagnosis and treatment of HIV/AIDS in China: Their potential benefits and impact on public healthYun He, Hongzhou Lu
Bioscience Trends|June 17, 2021
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19Jie Su, Hongzhou Lu
Drug Discoveries & Therapeutics|June 21, 2019
Immediate antiviral therapy for HIV-infected persons faces with various obstaclesQi Tang, Hongzhou Lu
Bioscience Trends|November 27, 2018
HIV/AIDS responses in China should focus on the impact of global integrationQi Tang, Hongzhou Lu
Bioscience Trends|July 18, 2014
Why are some HIV/AIDS patients reluctant to receive antiviral therapy as soon as possible in China?Yang Sun, Hongzhou Lu
Pageof 45

Showing results (11-20 of 444) with videos related to

Sort By:
Pageof 45
Drug Discoveries & Therapeutics|May 13, 2014
Suggestions to the media to help us cope with the A/H7N9 crisis in ChinaYang Sun, Hongzhou Lu
Global Health & Medicine|November 16, 2021
Prevalence, diagnosis, and treatment of hepatitis C in Mainland ChinaXue Mei, Hongzhou Lu
Bioscience Trends|March 22, 2021
New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antiviralsJun Chen, Hongzhou Lu
Bioscience Trends|April 8, 2016
Yellow fever in China is still an imported diseaseJun Chen, Hongzhou Lu
Drug Discoveries & Therapeutics|August 2, 2021
Less is more: A novel single-tablet regimen with two-drugs, dolutegravir/lamivudineJianjun Sun, Hongzhou Lu
Bioscience Trends|December 9, 2021
Clinical guidelines for the diagnosis and treatment of HIV/AIDS in China: Their potential benefits and impact on public healthYun He, Hongzhou Lu
Bioscience Trends|June 17, 2021
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19Jie Su, Hongzhou Lu
Drug Discoveries & Therapeutics|June 21, 2019
Immediate antiviral therapy for HIV-infected persons faces with various obstaclesQi Tang, Hongzhou Lu
Bioscience Trends|November 27, 2018
HIV/AIDS responses in China should focus on the impact of global integrationQi Tang, Hongzhou Lu
Bioscience Trends|July 18, 2014
Why are some HIV/AIDS patients reluctant to receive antiviral therapy as soon as possible in China?Yang Sun, Hongzhou Lu
Pageof 45